Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ovarian Neoplasms × larotrectinib × Clear all

Sponsor

Conditions

Central Nervous System Neoplasms 3 Wilms Tumor 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioma 2 Ependymoma 2 Xanthogranuloma, Juvenile 1 Sarcoma, Ewing 1 Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion 1 Histiocytic Sarcoma 1

Interventions

Paclitaxel 94 Carboplatin 81 Bevacizumab 61 Gemcitabine 35 liposomal doxorubicin 31 pembrolizumab 29 Topotecan 26 Taxes 23 olaparib 22 Immunoglobulin G 17 Disulfides 17 niraparib 16 Docetaxel 16 Cyclophosphamide 16 Cisplatin 14 rucaparib 10 durvalumab 10 Nivolumab 10 Doxorubicin 9 Albumin-Bound Paclitaxel 8 sargramostim 7 pazopanib 7 fludarabine phosphate 7 fludarabine 7 avelumab 7 Ifosfamide 7 epacadostat 6 Trabectedin 6 Sorafenib 6 Magnetic Resonance Spectroscopy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡